Label: ASPERCREME LIDOCAINE XL- lidocaine patch
- NDC Code(s): 62168-0585-2
- Packager: Lead Chemical Co., Ltd.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated January 2, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient
- Purpose
- Use
-
Warnings
For external use only
Do not use
- •
- on puncture wounds, cuts, irritated or swollen skin
- •
- more than 1 patch on your body at a time or with other topical analgesics at the same time
- •
- with a heating pad or apply local heat to the area of use
When using this product
- •
- use only as directed
- •
- do not bandage tightly
- •
- avoid contact with the eyes
- •
- dispose of used patch in manner that always keeps product away from children and pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.
-
Directions
adults and children 12 years of age and older:
- •
- clean and dry affected area
- •
- remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle
- •
- carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area
- •
- once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area
- •
- use 1 patch at a time and not more than 3 to 4 times daily
children 12 years or younger: consult a doctor
- Inactive ingredients
-
Package/Label Principal Display Panel
MAX STRENGTH
Aspercreme®
with 4% LIDOCAINE
PAIN RELIEF PATCH
NUMBS AWAY PAIN
FAST ACTING
TARGETS NERVES
FLEXIBLE FABRIC
#1 LIDOCAINE BRAND*XL PATCH
71% LARGER†FRAGRANCE-FREE
Contains 1 Patch 4-¾” x 7-7/8” (12 cm x 20 cm)
Pain Relieving Ointment on a Breathable Adhesive Pad*Among OTC topical analgesics.
†Than 10 cm x 14 cm Aspercreme® patches.
CHATTEM®
A SANOFI COMPANY
Dist. By Chattem, Inc., a Sanofi Company
P.O. Box 2219, Chattanooga, TN
37409-0219 USA
©2020
www.aspercreme.com Made in JapanLabel
-
INGREDIENTS AND APPEARANCE
ASPERCREME LIDOCAINE XL
lidocaine patchProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:62168-0585 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE 411.4 mg Inactive Ingredients Ingredient Name Strength DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS (UNII: 1K713C615K) ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0) CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311) GLYCERIN (UNII: PDC6A3C0OX) METHYLPARABEN (UNII: A2I8C7HI9T) NONOXYNOL-30 (UNII: JJX07DG188) POLYSORBATE 80 (UNII: 6OZP39ZG8H) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) TARTARIC ACID (UNII: W4888I119H) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) UREA (UNII: 8W8T17847W) WATER (UNII: 059QF0KO0R) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:62168-0585-2 240 in 1 CARTON 05/28/2021 1 1 in 1 POUCH; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug 505G(a)(3) 10/15/2017 Labeler - Lead Chemical Co., Ltd. (693727091)
